Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -37.76% |
| Q3 2025 | -94.04% |
| Q2 2025 | 10.53% |
| Q1 2025 | -13.32% |
| Q4 2024 | 22.18% |
| Q3 2024 | -89.55% |
| Q2 2024 | 43.56% |
| Q1 2024 | 21.33% |
| Q4 2023 | 4.47% |
| Q3 2023 | -0.08% |
| Q2 2023 | 29.00% |
| Q1 2023 | -47.58% |
| Q4 2022 | 5.24% |
| Q3 2022 | -11.17% |
| Q2 2022 | 31.81% |
| Q1 2022 | -38.32% |
| Q4 2021 | -73.37% |
| Q3 2021 | 32.25% |
| Q2 2021 | 9.26% |
| Q1 2021 | -51.34% |
| Q4 2020 | 8.97% |
| Q3 2020 | -52.23% |
| Q2 2020 | -7.67% |
| Q1 2020 | -38.90% |
| Q4 2019 | -1.51% |
| Q3 2019 | -40.25% |
| Q2 2019 | 45.41% |
| Q1 2019 | -26.60% |
| Q4 2018 | -39.52% |
| Q3 2018 | 10.83% |
| Q2 2018 | 18.99% |
| Q1 2018 | -37.43% |
| Q4 2017 | 2.38% |
| Q3 2017 | -15.76% |
| Q2 2017 | 9.05% |
| Q1 2017 | 11.92% |
| Q4 2016 | 35.14% |
| Q3 2016 | -4.97% |
| Q2 2016 | 48.37% |
| Q1 2016 | -29.99% |